1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
  4. > Global Markets and Technologies for Advanced Drug Delivery Systems

This BCC Research report analyzes the advanced drug delivery market by technologies/systems, applications, routes of administration and drug delivery vehicles. Forecast given for the period 2015-2020.

Use this report to:

Identify the market dynamics of global advanced drug delivery technologies and their relevant business impact.
Gain insight into the advanced drug delivery industry competitive landscape.
Analyze the advanced drug delivery market by technology, application, routes of administration, and drug delivery vehicle.
Gain information through patents on advanced drug delivery systems.

Highlights

The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%.
The North American market should grow from nearly $75.7 billion in 2015 to $93.4 billion by 2020, a CAGR of 4.3%.
The European market should grow from roughly $57.3 billion in 2015 to nearly $72.1 billion by 2020, a CAGR of 4.7%.

STUDY GOALS AND OBJECTIVES

The study’s goal is to provide industry participants insights into the global advanced drug delivery technologies market, both in terms of quantitative and qualitative data, which could help them gain an understanding of the market to develop business/growth strategies, assess the landscape, analyze their current position and make more informed business decisions. In particular, the study’s objectives include the following:

Provide comprehensive analysis of advanced drug delivery technologies, applications, routes of administration and drug delivery vehicles.
Identify the market dynamics of each key market and the relevant business impact hereof.
Offer market forecasting for four regions: North America, Europe, Asia and rest of the world (ROW).
Report and analyze key market developments.
Highlight and analyze market trends, drivers and restraints.
Analyze each key region listed above.
Analyze the market’s competitive landscape.

REASONS FOR DOING THE STUDY

Advances in medical science, research and development (R&D), and innovation are changing the dynamics of the life sciences industry, including biotechnology, pharmaceuticals and healthcare. The development of new drugs necessitates the development of different drug delivery systems, which is further driven by innovation in technology, R&D and scientific advancements.

Advances in understanding human biology, diseases and medical treatments are opening new opportunities in the pharmaceutical industry. A drug delivery system is an important area where the need for better technologies for drug administration/delivery is in demand.

A key driver of the growth in this industry is the advantages advanced drug delivery systems offer over traditional drug delivery systems, such as higher efficacy, localized treatment of diseases, duration of drug delivery, convenient routes of administration, better targeting and lower dosing frequency. For example, advanced drug delivery systems such as rectal drug delivery, lymphatic implants are more effective than traditional pharmaceuticals and promote better treatment outcomes (e.g., fewer side effects, continuous or extended release of the drug). Consequently, these developments are driving significant growth in the global drug delivery market.

Currently, the global market for advanced drug delivery systems is valued at over $150 billion. This report offers an overview of current and future market characteristics of advanced drug delivery systems. It provides a comprehensive view of current and emerging drug delivery technologies, market drivers and restraints, the competitive landscape, and market revenues by technology across different regions (the United States, Europe, Asia and ROW).

Table Of Contents

Global Markets and Technologies for Advanced Drug Delivery Systems
GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY
@bccresearch.com
CHAPTER 1 INTRODUCTION 2
STUDY GOALS AND OBJECTIVES 2
REASONS FOR DOING THE STUDY 2
SCOPE OF REPORT 3
INTENDED AUDIENCE 3
INFORMATION SOURCES AND METHODOLOGY 3
ANALYST'S CREDENTIALS 4
RELATED BCC RESEARCH REPORTS 4
BCC RESEARCH WEBSITE 4
DISCLAIMER 4
CHAPTER 2 SUMMARY 7
SUMMARY TABLE GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 7
SUMMARY FIGURE GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION,
2014-2020 ($ MILLIONS) 8
CHAPTER 3 OVERVIEW 10
ADVANCED DRUG DELIVERY MARKET EVOLUTION AND DYNAMICS 10
ADVANCED DRUG DELIVERY INDUSTRY LIFE/GROWTH STAGES 11
FIRST GENERATION - CONTROLLED/MODIFIED RELEASE TECHNOLOGIES 11
SECOND GENERATION - NEW WAVE OF ADVANCED DRUG DELIVERY
TECHNOLOGIES WITH EMERGENCE OF SMART DRUG DELIVERY 12
THIRD GENERATION - NEW FRONTIER OF ADVANCED DRUG DELIVERY
WITH SIGNIFICANT ADVANCES IN MODIFIED DELIVERY SYSTEMS 12
MULTIPLE-RELEASE TECHNOLOGY MARKET 12
FIXED DOSE COMBINATION MULTIPLE RELEASE TECHNOLOGY - MAJOR
PHASE OF NEXT GENERATION ADVANCED DRUG DELIVERY MARKET. 13
MARKET DRIVERS AND RESTRAINTS 14
GLOBAL ADVANCED DRUG DELIVERY MARKET ANALYSIS 16
FIGURE 1 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY
REGION, 2015 (%) 16
FIGURE 2 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY
TECHNOLOGIES/SYSTEMS, 2015 (%) 17
FIGURE 3 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY
TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION (2015) (%) 18
COMPETITIVE LANDSCAPE 20
PATENT ANALYSIS 21
FIGURE 4 PATENT ANALYSIS BY PATENT JURISDICTION, 2014-DECEMBER 2015 (%) 21
CHAPTER 4 ADVANCED DRUG DELIVERY TECHNOLOGIES/SYSTEMS MARKET 24
TABLE 1 GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 25
TABLE 2 GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY TYPE,
THROUGH 2020 ($ MILLIONS) 25
FIGURE 5 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY RELEASE
TECHNOLOGIES/SYSTEMS, 2015 (%) 26
ADVANCED IMMEDIATE-RELEASE TECHNOLOGY 26
DRIVERS AND RESTRAINTS 29
TABLE 3 GLOBAL ADVANCED IMMEDIATE-RELEASE TECHNOLOGY MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 30
MODIFIED DRUG DELIVERY 30
TABLE 4 GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 31
TABLE 5 GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 32
TARGETED DRUG DELIVERY TECHNOLOGY 32
Drivers and Restraints 32
Market Analysis 33
Future Outlook 34
Market Players 34
TABLE 6 GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY
VEHICLES, THROUGH 2020 ($ MILLIONS) 35
TABLE 7 GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY ROUTE OF
ADMINISTRATION, THROUGH 2020 ($ MILLIONS) 35
TABLE 8 GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 36
EXTENDED DRUG RELEASE 36
TABLE 9 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY
VEHICLE, THROUGH 2020 ($ MILLIONS) 37
TABLE 10 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY ROUTE OF
ADMINISTRATION, THROUGH 2020 ($ MILLIONS) 37
TABLE 11 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY TYPE, THROUGH
2020 ($ MILLIONS) 37
TABLE 12 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 37
SUSTAINED AND CONTROLLED RELEASE DRUG DELIVERY SYSTEMS 38
Drivers and Restraints 39
Market Analysis and Future Outlook 40
Market Players 42
TABLE 13 GLOBAL SUSTAINED-RELEASE TECHNOLOGY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 42
TABLE 14 GLOBAL CONTROLLED-RELEASE TECHNOLOGY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 43
DELAYED RELEASE AND PULSATILE RELEASE DRUG DELIVERY
TECHNOLOGY 43
Market Analysis 44
Drivers and Restraints 45
Market Players 45
TABLE 15 GLOBAL DELAYED-RELEASE TECHNOLOGY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 45
TABLE 16 GLOBAL PULSATILE-RELEASE TECHNOLOGY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 46
CHAPTER 5 MARKET BY ROUTE OF ADMINISTRATION 48
TABLE 17 GLOBAL ADVANCED DRUG DELIVERY MARKET BY ROUTES OF
ADMINISTRATION, THROUGH 2020 ($ MILLIONS) 48
FIGURE 6 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY
TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION, 2015 (%) 48
ORAL DRUG DELIVERY MARKET 49
MARKET DRIVERS AND RESTRAINTS/CHALLENGES 50
MARKET ANALYSIS - INNOVATIONS, DEVELOPMENTS AND KEY
COMPETITIVE FACTORS 50
TABLE 18 EXAMPLES OF ORAL FAST-DISSOLVED/DISINTEGRATED (FDTS)
TECHNOLOGIES AND PRODUCTS 51
Opportunities/Future Outlook 53
MARKET PLAYERS 54
TABLE 19 GLOBAL ORAL ADVANCED DRUG DELIVERY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 54
PARENTERAL/INJECTABLE DRUG DELIVERY MARKET 54
DRIVERS AND RESTRAINTS 56
MARKET ANALYSIS - INNOVATIONS, DEVELOPMENTS AND KEY
COMPETITIVE FACTORS 56
FUTURE OUTLOOK/OPPORTUNITIES 59
MARKET PLAYERS 59
TABLE 20 GLOBAL INJECTABLE ADVANCED DRUG DELIVERY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 60
TOPICAL DRUG DELIVERY MARKET 60
MARKET ANALYSIS - DEVELOPMENTS AND INNOVATIONS 60
MARKET DRIVERS AND RESTRAINTS 61
MARKET PLAYERS 62
TABLE 21 GLOBAL TOPICAL ADVANCED DRUG DELIVERY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 62
TRANSDERMAL DRUG DELIVERY 62
MARKET DRIVERS AND RESTRAINTS 63
MARKET ANALYSIS - PRODUCT EXAMPLES, INNOVATION AND FUTURE
OUTLOOK 63
FUTURE OUTLOOK/OPPORTUNITIES 66
MARKET PLAYERS 66
TABLE 22 GLOBAL TRANSDERMAL ADVANCED DRUG DELIVERY MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 66
TRANSMUCOSAL MARKET 67
MARKET DRIVERS AND RESTRAINTS 67
MARKET PLAYERS 67
TABLE 23 GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 67
TABLE 24 GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY TYPE,
THROUGH 2020 ($ MILLIONS) 68
NASAL AND PULMONARY MARKET 68
Market Drivers and Analysis 69
TABLE 25 GLOBAL TRANSMUCOSAL NASAL AND PULMONARY ADVANCED DRUG
DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 70
OCULAR DRUG DELIVERY 70
Market Analysis 70
TABLE 26 GLOBAL TRANSMUCOSAL OCULAR ADVANCED DRUG DELIVERY MARKET
BY REGION, THROUGH 2020 ($ MILLIONS) 71
ORAL - BUCCAL DRUG DELIVERY 71
Market Analysis 72
TABLE 27 GLOBAL TRANSMUCOSAL ORAL BUCCAL ADVANCED DRUG DELIVERY
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 72
VAGINAL DRUG DELIVERY 73
TABLE 28 GLOBAL TRANSMUCOSAL VAGINAL ADVANCED DRUG DELIVERY MARKET
BY REGION, THROUGH 2020 ($ MILLIONS) 73
RECTAL DRUG DELIVERY 73
TABLE 29 GLOBAL TRANSMUCOSAL RECTAL ADVANCED DRUG DELIVERY MARKET
BY REGION, THROUGH 2020 ($ MILLIONS) 74
IMPLANTS DRUG DELIVERY 74
MARKET DRIVERS AND RESTRAINTS 74
MARKET ANALYSIS AND FUTURE OUTLOOK 75
MARKET PLAYERS 77
TABLE 30 GLOBAL IMPLANTS ADVANCED DRUG DELIVERY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 78
CONTRACEPTIVE DEVICES 78
TABLE 31 GLOBAL CONTRACEPTIVE DEVICES FOR ADVANCED DRUG DELIVERY
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 79
CHAPTER 6 MARKET BY DRUG DELIVERY VEHICLES/CARRIERS 81
TABLE 32 GLOBAL ADVANCED DRUG DELIVERY VEHICLES/CARRIERS MARKET BY
TYPE, THROUGH 2020 ($ MILLIONS) 81
FIGURE 7 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY
DRUG VEHICLES/CARRIERS, 2015 (%) 81
LIPOSOMES 82
MARKET ANALYSIS AND FUTURE OUTLOOK 83
TABLE 33 GLOBAL LIPOSOMES MARKET IN ADVANCED DRUG DELIVERY BY REGION,
THROUGH 2020 ($ MILLIONS) 84
POLYMERIC THERAPEUTICS 84
TABLE 34 GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG
DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS) 85
TABLE 35 GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG
DELIVERY BY TYPE, THROUGH 2020 ($ MILLIONS) 85
MICELLES AND DENDRIMERS 85
Polymeric Micelles (Micelles) 85
Market Analysis 86
TABLE 36 GLOBAL POLYMERIC MICELLES MARKET IN ADVANCED DRUG DELIVERY
BY REGION, THROUGH 2020 ($ MILLIONS) 86
Dendrimers 87
Market Analysis 87
TABLE 37 GLOBAL DENDRIMERS MARKET IN ADVANCED DRUG DELIVERY BY
REGION, THROUGH 2020 ($ MILLIONS) 88
POLYMERS (POLYMERIC DRUG DELIVERY) 88
Market Analysis 88
Reservoir-based Systems 89
Monolithic Matrix Systems 89
Polymer-drug Conjugate Systems 90
TABLE 38 GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY
REGION, THROUGH 2020 ($ MILLIONS) 90
TABLE 39 GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY
TYPE OF DRUG SYSTEM, THROUGH 2020 ($ MILLIONS) 91
NANOCARRIERS/NANOPARTICLES 91
TABLE 40 GLOBAL NANOCARRIERS/NANOPARTICLES MARKET IN ADVANCED DRUG
DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS) 92
MICROPARTICLES/MICROSPHERES 92
TABLE 41 GLOBAL MICROPARTICLES/MICROSPHERES MARKET IN ADVANCED DRUG
DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS) 94
MONOCLONAL ANTIBODIES (MABS) 94
TABLE 42 GLOBAL MONOCLONAL ANTIBODIES MARKET IN ADVANCED DRUG
DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS) 95
PRODRUGS 96
TABLE 43 GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY REGION,
THROUGH 2020 ($ MILLIONS) 97
TABLE 44 GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY TYPE,
THROUGH 2020 ($ MILLIONS) 98
OTHERS 98
TABLE 45 GLOBAL OTHER DRUG DELIVERY VEHICLES/CARRIERS MARKET IN
ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS) 98
CHAPTER 7 MARKET BY APPLICATIONS 101
TABLE 46 GLOBAL ADVANCED DRUG DELIVERY MARKET BY APPLICATION,
THROUGH 2020 ($ MILLIONS) 101
FIGURE 8 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY
TECHNOLOGIES/SYSTEMS BY APPLICATION, 2015 (%) 101
CARDIOVASCULAR 102
TABLE 47 GLOBAL ADVANCED DRUG DELIVERY CARDIOVASCULAR APPLICATIONS
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 104
ONCOLOGY MARKET 104
TABLE 48 GLOBAL ADVANCED DRUG DELIVERY ONCOLOGY APPLICATIONS MARKET
BY REGION, THROUGH 2020 ($ MILLIONS) 106
GASTROINTESTINAL DISORDERS 107
TABLE 49 GLOBAL ADVANCED DRUG DELIVERY GASTROINTESTINAL APPLICATIONS
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 108
UROLOGY 108
TABLE 50 GLOBAL ADVANCED DRUG DELIVERY UROLOGY APPLICATIONS MARKET
BY REGION, THROUGH 2020 ($ MILLIONS) 109
DIABETES 110
TABLE 51 GLOBAL ADVANCED DRUG DELIVERY DIABETES APPLICATIONS MARKET
BY REGION, THROUGH 2020 ($ MILLIONS) 111
DERMATOLOGY 111
TABLE 52 GLOBAL ADVANCED DRUG DELIVERY DERMATOLOGY APPLICATIONS
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 112
CENTRAL NERVOUS SYSTEM 112
TABLE 53 GLOBAL ADVANCED DRUG DELIVERY CENTRAL NERVOUS SYSTEM
APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 114
RESPIRATORY DRUG DELIVERY SYSTEMS 114
TABLE 54 GLOBAL ADVANCED DRUG DELIVERY RESPIRATORY APPLICATIONS
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 115
INFLAMMATORY DISEASES AND ALLERGIES 115
TABLE 55 GLOBAL ADVANCED DRUG DELIVERY INFLAMMATORY DISEASES AND
ALLERGIES APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 116
OPHTHALMOLOGY 116
TABLE 56 GLOBAL ADVANCED DRUG DELIVERY OPHTHALMOLOGY APPLICATIONS
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 118
VIRAL AND BACTERIAL DISEASES 118
TABLE 57 GLOBAL ADVANCED DRUG DELIVERY VIRAL AND BACTERIAL DISEASES
APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 119
HORMONE REPLACEMENT THERAPY AND GYNECOLOGY 119
TABLE 58 GLOBAL ADVANCED DRUG DELIVERY HORMONAL REPLACEMENT
THERAPY AND GYNECOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020
($ MILLIONS)
120
OTHER THERAPEUTIC CATEGORIES 120
TABLE 59 GLOBAL ADVANCED DRUG DELIVERY OTHER THERAPEUTIC
APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 121
CHAPTER 8 COMPETITIVE DEVELOPMENTS 123
INTRODUCTION 123
FIGURE 9 DEVELOPMENTS IN GLOBAL PATIENT MONITORING DEVICES MARKET,
2013-DECEMBER 2015 (%) 124
TABLE 60 DEVELOPMENTS - PRODUCT LAUNCH/APPROVAL/UPDATE, 2013- DEC
2015 125
TABLE 61 DEVELOPMENTS - COLLABORATIONS/PARTNERSHIPS/AGREEMENTS,
2013- DEC 2015 133
TABLE 62 DEVELOPMENTS - ACQUISITIONS AND MERGERS, 2013- DEC 2015 138
TABLE 63 DEVELOPMENTS - MISCELLANEOUS, 2013- OCT 2015 143
CHAPTER 9 REGIONAL ANALYSIS 146
NORTH AMERICA 146
TABLE 64 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY
TECHNOLOGY, THROUGH 2020 ($ MILLIONS) 147
TABLE 65 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF
ADMINISTRATION, THROUGH 2020 ($ MILLIONS) 147
TABLE 66 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY APPLICATION,
THROUGH 2020 ($ MILLIONS) 148
TABLE 67 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY DRUG
VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS) 148
EUROPE 149
TABLE 68 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY,
THROUGH 2020 ($ MILLIONS) 149
TABLE 69 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF
ADMINISTRATION, THROUGH 2020 ($ MILLIONS) 150
TABLE 70 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS,
THROUGH 2020 ($ MILLIONS) 150
TABLE 71 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY DRUG
VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS) 151
ASIA-PACIFIC 151
TABLE 72 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY,
THROUGH 2020 ($ MILLIONS) 152
TABLE 73 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY ROUTE OF
ADMINISTRATION, THROUGH 2020 ($ MILLIONS) 152
TABLE 74 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS,
THROUGH 2020 ($ MILLIONS) 153
TABLE 75 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY DRUG
VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS) 153
REST OF THE WORLD (ROW) 154
TABLE 76 ROW ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH
2020 ($ MILLIONS) 154
TABLE 77 ROW ADVANCED DRUG DELIVERY MARKET BY ROUTE OF
ADMINISTRATION, THROUGH 2020 ($ MILLIONS) 155
TABLE 78 ROW ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH
2020 ($ MILLIONS) 155
TABLE 79 ROW ADVANCED DRUG DELIVERY MARKET BY DRUG
VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS) 156
CHAPTER 10 APPENDIX 158
TABLE 80 LIST (EXAMPLES) OF PATENTS, 2015 158
TABLE 81 LIST (EXAMPLES) PATENTS, 2014 167
CHAPTER 11 COMPANY PROFILES 180
3M COMPANY 180
ABBOTT LABORATORIES 180
ALLERGAN PLC 181
AKELA PHARMA INC. 182
ALCON INC. (NOVARTIS COMPANY) 182
AMGEN INC. 182
A.P. PHARMA/ HERON THERAPEUTICS, INC. 183
APTALIS PHARMA INC. /ADARE PHARMACEUTICALS 183
ALKERMES 184
ASTELLAS PHARMA INC. 184
ASTRAZENECA PLC 185
BAUSCH and LOMB 185
BAXTER INTERNATIONAL INC. 186
BAYER HEALTHCARE PHARMACEUTICALS 186
BIOGEN IDEC 187
BIOSANTE PHARMACEUTICALS INC. 187
BOEHRINGER INGELHEIM 187
BOSTON SCIENTIFIC 188
BRISTOL-MYERS SQUIBB 189
CAPSUGEL 189
CATALENT 190
CELGENE CORP. 190
EISAI CO. LTD. 190
ELAN DRUG TECHNOLOGIES/PERRIGO COMPANY 191
ENZON PHARMACEUTICALS 192
ELIXIR MEDICAL CORP. 192
FLAMEL TECHNOLOGIES 193
GENENTECH INC. 193
GENEREX BIOTECHNOLOGY CORP. 194
GENZYME CORP. 194
GILEAD SCIENCES INC. 195
GLAXOSMITHKLINE PLC 195
HISAMITSU PHARMACEUTICAL CO. INC. 196
ELI LILLY and IMCLONE SYSTEMS 196
JANSSEN BIOTECH INC. 197
JOHNSON and JOHNSON 197
KEMPHARM INC. 198
KYOTO MEDICAL PLANNING CO. LTD. 198
MANNKIND CORP. 199
MEDTRONIC 199
MERCK and CO. 200
MYLAN LABORATORIES INC. 200
NEKTAR THERAPEUTICS 201
NEWGEN BIOPHARMA 201
NOVARTIS AG 201
NOVAVAX INC. 202
NOVEN PHARMACEUTICALS INC. 202
PAR PHARMACEUTICAL COMPANIES INC. 203
PDL BIOPHARMA INC. 203
PFIZER INC. 204
ROCHE HOLDING AG 204
SANOFI SA 205
SKYEPHARMA 205
TEVA PHARMACEUTICAL INDUSTRIES LTD. 206
THERAJECT INC. 206
VALEANT PHARMACEUTICALS INTERNATIONAL INC. 206
XEL PHARMACEUTICALS INC. 207

LIST OF TABLES

SUMMARY TABLE GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 7
TABLE 1 GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 25
TABLE 2 GLOBAL ADVANCED DRUG DELIVERY TECHNOLOGIES MARKET BY TYPE,
THROUGH 2020 ($ MILLIONS) 25
TABLE 3 GLOBAL ADVANCED IMMEDIATE-RELEASE TECHNOLOGY MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 30
TABLE 4 GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH
2020 ($ MILLIONS) 31
TABLE 5 GLOBAL MODIFIED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH
2020 ($ MILLIONS) 32
TABLE 6 GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY
VEHICLES, THROUGH 2020 ($ MILLIONS) 35
TABLE 7 GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY ROUTE OF
ADMINISTRATION, THROUGH 2020 ($ MILLIONS) 35
TABLE 8 GLOBAL TARGETED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH
2020 ($ MILLIONS) 36
TABLE 9 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY DRUG DELIVERY
VEHICLE, THROUGH 2020 ($ MILLIONS) 37
TABLE 10 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY ROUTE OF
ADMINISTRATION, THROUGH 2020 ($ MILLIONS) 37
TABLE 11 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY TYPE, THROUGH
2020 ($ MILLIONS) 37
TABLE 12 GLOBAL EXTENDED-RELEASE TECHNOLOGY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 37
TABLE 13 GLOBAL SUSTAINED-RELEASE TECHNOLOGY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 42
TABLE 14 GLOBAL CONTROLLED-RELEASE TECHNOLOGY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 43
TABLE 15 GLOBAL DELAYED-RELEASE TECHNOLOGY MARKET BY REGION, THROUGH
2020 ($ MILLIONS) 45
TABLE 16 GLOBAL PULSATILE-RELEASE TECHNOLOGY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 46
TABLE 17 GLOBAL ADVANCED DRUG DELIVERY MARKET BY ROUTES OF
ADMINISTRATION, THROUGH 2020 ($ MILLIONS) 48
TABLE 18 EXAMPLES OF ORAL FAST-DISSOLVED/DISINTEGRATED (FDTS)
TECHNOLOGIES AND PRODUCTS 51
TABLE 19 GLOBAL ORAL ADVANCED DRUG DELIVERY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 54
TABLE 20 GLOBAL INJECTABLE ADVANCED DRUG DELIVERY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 60
TABLE 21 GLOBAL TOPICAL ADVANCED DRUG DELIVERY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 62
TABLE 22 GLOBAL TRANSDERMAL ADVANCED DRUG DELIVERY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 66
TABLE 23 GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 67
TABLE 24 GLOBAL TRANSMUCOSAL ADVANCED DRUG DELIVERY MARKET BY TYPE,
THROUGH 2020 ($ MILLIONS) 68
TABLE 25 GLOBAL TRANSMUCOSAL NASAL AND PULMONARY ADVANCED DRUG
DELIVERY MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 70
TABLE 26 GLOBAL TRANSMUCOSAL OCULAR ADVANCED DRUG DELIVERY MARKET
BY REGION, THROUGH 2020 ($ MILLIONS) 71
TABLE 27 GLOBAL TRANSMUCOSAL ORAL BUCCAL ADVANCED DRUG DELIVERY
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 72
TABLE 28 GLOBAL TRANSMUCOSAL VAGINAL ADVANCED DRUG DELIVERY MARKET
BY REGION, THROUGH 2020 ($ MILLIONS) 73
TABLE 29 GLOBAL TRANSMUCOSAL RECTAL ADVANCED DRUG DELIVERY MARKET
BY REGION, THROUGH 2020 ($ MILLIONS) 74
TABLE 30 GLOBAL IMPLANTS ADVANCED DRUG DELIVERY MARKET BY REGION,
THROUGH 2020 ($ MILLIONS) 78
TABLE 31 GLOBAL CONTRACEPTIVE DEVICES FOR ADVANCED DRUG DELIVERY
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 79
TABLE 32 GLOBAL ADVANCED DRUG DELIVERY VEHICLES/CARRIERS MARKET BY
TYPE, THROUGH 2020 ($ MILLIONS) 81
TABLE 33 GLOBAL LIPOSOMES MARKET IN ADVANCED DRUG DELIVERY BY REGION,
THROUGH 2020 ($ MILLIONS) 84
TABLE 34 GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG
DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS) 85
TABLE 35 GLOBAL POLYMERIC THERAPEUTICS MARKET IN ADVANCED DRUG
DELIVERY BY TYPE, THROUGH 2020 ($ MILLIONS) 85
TABLE 36 GLOBAL POLYMERIC MICELLES MARKET IN ADVANCED DRUG DELIVERY BY
REGION, THROUGH 2020 ($ MILLIONS) 86
TABLE 37 GLOBAL DENDRIMERS MARKET IN ADVANCED DRUG DELIVERY BY REGION,
THROUGH 2020 ($ MILLIONS) 88
TABLE 38 GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY
REGION, THROUGH 2020 ($ MILLIONS) 90
TABLE 39 GLOBAL POLYMERIC DRUGS MARKET IN ADVANCED DRUG DELIVERY BY
TYPE OF DRUG SYSTEM, THROUGH 2020 ($ MILLIONS) 91
TABLE 40 GLOBAL NANOCARRIERS/NANOPARTICLES MARKET IN ADVANCED DRUG
DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS) 92
TABLE 41 GLOBAL MICROPARTICLES/MICROSPHERES MARKET IN ADVANCED DRUG
DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS) 94
TABLE 42 GLOBAL MONOCLONAL ANTIBODIES MARKET IN ADVANCED DRUG
DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS) 95
TABLE 43 GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY REGION,
THROUGH 2020 ($ MILLIONS) 97
TABLE 44 GLOBAL PRODRUGS MARKET IN ADVANCED DRUG DELIVERY BY TYPE,
THROUGH 2020 ($ MILLIONS) 98
TABLE 45 GLOBAL OTHER DRUG DELIVERY VEHICLES/CARRIERS MARKET IN
ADVANCED DRUG DELIVERY BY REGION, THROUGH 2020 ($ MILLIONS) 98
TABLE 46 GLOBAL ADVANCED DRUG DELIVERY MARKET BY APPLICATION, THROUGH
2020 ($ MILLIONS) 101
TABLE 47 GLOBAL ADVANCED DRUG DELIVERY CARDIOVASCULAR APPLICATIONS
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 104
TABLE 48 GLOBAL ADVANCED DRUG DELIVERY ONCOLOGY APPLICATIONS MARKET
BY REGION, THROUGH 2020 ($ MILLIONS) 106
TABLE 49 GLOBAL ADVANCED DRUG DELIVERY GASTROINTESTINAL APPLICATIONS
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 108
TABLE 50 GLOBAL ADVANCED DRUG DELIVERY UROLOGY APPLICATIONS MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 109
TABLE 51 GLOBAL ADVANCED DRUG DELIVERY DIABETES APPLICATIONS MARKET BY
REGION, THROUGH 2020 ($ MILLIONS) 111
TABLE 52 GLOBAL ADVANCED DRUG DELIVERY DERMATOLOGY APPLICATIONS
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 112
TABLE 53 GLOBAL ADVANCED DRUG DELIVERY CENTRAL NERVOUS SYSTEM
APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 114
TABLE 54 GLOBAL ADVANCED DRUG DELIVERY RESPIRATORY APPLICATIONS
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 115
TABLE 55 GLOBAL ADVANCED DRUG DELIVERY INFLAMMATORY DISEASES AND
ALLERGIES APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 116
TABLE 56 GLOBAL ADVANCED DRUG DELIVERY OPHTHALMOLOGY APPLICATIONS
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 118
TABLE 57 GLOBAL ADVANCED DRUG DELIVERY VIRAL AND BACTERIAL DISEASES
APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 119
TABLE 58 GLOBAL ADVANCED DRUG DELIVERY HORMONAL REPLACEMENT THERAPY
AND GYNECOLOGY APPLICATIONS MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 120
TABLE 59 GLOBAL ADVANCED DRUG DELIVERY OTHER THERAPEUTIC APPLICATIONS
MARKET BY REGION, THROUGH 2020 ($ MILLIONS) 121
TABLE 60 DEVELOPMENTS - PRODUCT LAUNCH/APPROVAL/UPDATE, 2013- DEC 2015 125
TABLE 61 DEVELOPMENTS - COLLABORATIONS/PARTNERSHIPS/AGREEMENTS, 2013-
DEC 2015 133
TABLE 62 DEVELOPMENTS - ACQUISITIONS AND MERGERS, 2013- DEC 2015 138
TABLE 63 DEVELOPMENTS - MISCELLANEOUS, 2013- OCT 2015 143
TABLE 64 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY,
THROUGH 2020 ($ MILLIONS) 147
TABLE 65 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF
ADMINISTRATION, THROUGH 2020 ($ MILLIONS) 147
TABLE 66 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY APPLICATION,
THROUGH 2020 ($ MILLIONS) 148
TABLE 67 NORTH AMERICAN ADVANCED DRUG DELIVERY MARKET BY DRUG
VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS) 148
TABLE 68 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY,
THROUGH 2020 ($ MILLIONS) 149
TABLE 69 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY ROUTE OF
ADMINISTRATION, THROUGH 2020 ($ MILLIONS) 150
TABLE 70 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS,
THROUGH 2020 ($ MILLIONS) 150
TABLE 71 EUROPEAN ADVANCED DRUG DELIVERY MARKET BY DRUG
VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS) 151
TABLE 72 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY,
THROUGH 2020 ($ MILLIONS) 152
TABLE 73 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY ROUTE OF
ADMINISTRATION, THROUGH 2020 ($ MILLIONS) 152
TABLE 74 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS,
THROUGH 2020 ($ MILLIONS) 153
TABLE 75 ASIA-PACIFIC ADVANCED DRUG DELIVERY MARKET BY DRUG
VEHICLES/CARRIERS, THROUGH 2020 ($ MILLIONS) 153
TABLE 76 ROW ADVANCED DRUG DELIVERY MARKET BY TECHNOLOGY, THROUGH
2020 ($ MILLIONS) 154
TABLE 77 ROW ADVANCED DRUG DELIVERY MARKET BY ROUTE OF
ADMINISTRATION, THROUGH 2020 ($ MILLIONS) 155
TABLE 78 ROW ADVANCED DRUG DELIVERY MARKET BY APPLICATIONS, THROUGH
2020 ($ MILLIONS) 155
TABLE 79 ROW ADVANCED DRUG DELIVERY MARKET BY DRUG VEHICLES/CARRIERS,
THROUGH 2020 ($ MILLIONS) 156
TABLE 80 LIST (EXAMPLES) OF PATENTS, 2015 158
TABLE 81 LIST (EXAMPLES) PATENTS, 2014 167

LIST OF FIGURES

SUMMARY FIGURE GLOBAL ADVANCED DRUG DELIVERY MARKET BY REGION,
2014-2020 ($ MILLIONS) 8
FIGURE 1 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY
REGION, 2015 (%) 16
FIGURE 2 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY
TECHNOLOGIES/SYSTEMS, 2015 (%) 17
FIGURE 3 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY
TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION (2015) (%) 18
FIGURE 4 PATENT ANALYSIS BY PATENT JURISDICTION, 2014-DECEMBER 2015 (%) 21
FIGURE 5 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY RELEASE
TECHNOLOGIES/SYSTEMS, 2015 (%) 26
FIGURE 6 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY
TECHNOLOGIES/SYSTEMS BY ROUTE OF ADMINISTRATION, 2015 (%) 48
FIGURE 7 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY MARKET BY DRUG
VEHICLES/CARRIERS, 2015 (%) 81
FIGURE 8 MARKET SHARE IN GLOBAL ADVANCED DRUG DELIVERY
TECHNOLOGIES/SYSTEMS BY APPLICATION, 2015 (%) 101
FIGURE 9 DEVELOPMENTS IN GLOBAL PATIENT MONITORING DEVICES MARKET,
2013-DECEMBER 2015 (%) 124

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
North American Drug Delivery Technologies Market by Route of Administration, Pulmonary, Injectable, Ocular, Nasal, Topical, Implantable), End User - Global Forecast to 2021

North American Drug Delivery Technologies Market by Route of Administration, Pulmonary, Injectable, Ocular, Nasal, Topical, Implantable), End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The North American drug delivery technologies market is projected to reach USD 758.7 billion by 2021 from USD 520.0 billion in 2016, at a CAGR of 6.5% during the forecast period. Major factors contributing ...

European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

  • $ 4995
  • Industry report
  • September 2016
  • by iData Research, Inc.

The European diabetes diagnosis, treatment and drug delivery market increased in 2015 and growth is expected to persist over the forecast period. Market growth will be driven by the growing prevalence ...

Injectable Drug Delivery Market Analysis, By Device Type, By Formulation, By Therapeutic Use, By End-user Application, By Region And Segment Forecasts From 2013 to 2024

Injectable Drug Delivery Market Analysis, By Device Type, By Formulation, By Therapeutic Use, By End-user Application, By Region And Segment Forecasts From 2013 to 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The global injectable drug delivery market is expected to reach USD 931.1 billion by 2024, according to a new report by Grand View Research, Inc. The increase in number of chronic diseases like diabetes ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.